Skip to main content
logo
Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
17.92
-1.10 (-5.78%)
At close: May 15, 2026, 4:00 PM EDT
17.93
+0.01 (0.06%)
After-hours: May 15, 2026, 4:10 PM EDT

Lyell Immunopharma Revenue

Lyell Immunopharma had revenue of $2.00K in the quarter ending March 31, 2026, a decrease of -71.43%. This brings the company's revenue in the last twelve months to $31.00K, down -52.31% year-over-year. In the year 2025, Lyell Immunopharma had annual revenue of $36.00K, down -40.98%.

Revenue (ttm)
$31.00K
Revenue Growth
-52.31%
P/S Ratio
13,487.70
Revenue / Employee
$103
Employees
300
Market Cap
418.12M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202536.00K-25.00K-40.98%
Dec 31, 202461.00K-69.00K-53.08%
Dec 31, 2023130.00K-84.55M-99.85%
Dec 31, 202284.68M74.03M695.15%
Dec 31, 202110.65M2.89M37.31%
Dec 31, 20207.76M7.10M1,080.52%
Dec 31, 2019657.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Century Therapeutics109.16M
Autolus Therapeutics92.62M
ADC Therapeutics79.18M
vTv Therapeutics36.84M
PureTech Health4.66M
Revenue Rankings

LYEL News

More News